Brief: iNtRON Biotechnology receives patent
25/01/2017 02:08
Jan 25 (Reuters) - iNtRON Biotechnology Inc 048530.KQ :
* Says it received U.S. patent on Jan. 25, for composition
capable of improving stability of bacteriophage lysin proteins
Source text in Korean: https://goo.gl/b39iTN
Further company coverage: 048530.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))